Foresite Capital Fund Iv, L.p. - Net Worth and Insider Trading
Foresite Capital Fund Iv, L.p. Net Worth
The estimated net worth of Foresite Capital Fund Iv, L.p. is at least $36 Million dollars as of 2024-06-10. Foresite Capital Fund Iv, L.p. is the 10% Owner of Kinnate Biopharma Inc and owns about 13,718,311 shares of Kinnate Biopharma Inc (KNTE) stock worth over $36 Million. Details can be seen in Foresite Capital Fund Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Foresite Capital Fund Iv, L.p. has not made any transactions after 2023-05-08 and currently still holds the listed stock(s).
Transaction Summary of Foresite Capital Fund Iv, L.p.
Foresite Capital Fund Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Foresite Capital Fund Iv, L.p. owns 4 companies in total, including Aerie Pharmaceuticals Inc (AERI) , 10x Genomics Inc (TXG) , and Aclaris Therapeutics Inc (ACRS) among others .
Click here to see the complete history of Foresite Capital Fund Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Foresite Capital Fund Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AERI | Aerie Pharmaceuticals Inc | 2019-08-12 | 10 percent owner |
| TXG | 10x Genomics Inc | 2019-09-11 | 10 percent owner |
| ACRS | Aclaris Therapeutics Inc | 2021-02-05 | 10 percent owner |
 | | 2023-05-08 | 10 percent owner |
Foresite Capital Fund Iv, L.p. Latest Holdings Summary
Foresite Capital Fund Iv, L.p. currently owns a total of 1 stock. Foresite Capital Fund Iv, L.p. owns 13,718,311 shares of Kinnate Biopharma Inc (KNTE) as of May 8, 2023, with a value of $36 Million.
Latest Holdings of Foresite Capital Fund Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc | 2023-05-08 | 13,718,311 | 2.65 | 36,353,524 |
Holding Weightings of Foresite Capital Fund Iv, L.p.
Foresite Capital Fund Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Foresite Capital Fund Iv, L.p. has made a total of 1 transactions in Kinnate Biopharma Inc (KNTE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kinnate Biopharma Inc is the acquisition of 1,780,000 shares on May 8, 2023, which cost Foresite Capital Fund Iv, L.p. around $5 Million.
Insider Trading History of Foresite Capital Fund Iv, L.p.
- 1
Foresite Capital Fund Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Foresite Capital Fund Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Foresite Capital Fund Iv, L.p. is -14.84%. GuruFocus also compares Foresite Capital Fund Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Foresite Capital Fund Iv, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Foresite Capital Fund Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Foresite Capital Fund Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.32 | | | | | |
| Relative Return to S&P 500(%) | 16.55 | | | | | |
Foresite Capital Fund Iv, L.p. Ownership Network
Foresite Capital Fund Iv, L.p. Owned Company Details
What does Aerie Pharmaceuticals Inc do?
Who are the key executives at Aerie Pharmaceuticals Inc?
Foresite Capital Fund Iv, L.p. is the 10 percent owner of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .
Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerie Pharmaceuticals Inc Insider Transactions
Foresite Capital Fund Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Foresite Capital Fund Iv, L.p.. You might contact Foresite Capital Fund Iv, L.p. via mailing address: 600 Montgomery Street, Suite 4500, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
